MedTrace Logo

Predictors of Rejection in Pediatric Kidney Transplantation

NCT04292418 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2020-03-03

No results posted yet for this study

Summary

Renal transplantation is the best option among the end-stage renal disease (ESRD) treatment alternatives, It is also relatively less expensive than dialysis. Allograft rejection is a major issue in kidney transplantation. Rejection is classified as acute or chronic, cellular or antibody-mediated.Children with kidney transplants require life-long immunosuppressive therapy to prevent rejection of the allograft

Conditions

  • Rejection Acute Renal

Interventions

DRUG

Tacrolimus capsule , mycophenolic acid

measuring tacrolimus level by elisa test then correlated with hematocrit level measuring mycophenolic acid by elisa test for study group 1 and study group 2

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-05-01
Completion
2021-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04292418 on ClinicalTrials.gov